注射可能式ドラッグデリバリーの世界市場2022-2028:種類別、使用法別、流通チャネル別、地域別

【英語タイトル】Global Injectable Drug Delivery Market Size study, by Type (Self-Injectors, Needle-free Injectors, Auto-Injectors), by Usage (Disposable, Reusable), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, E-commerce) and Regional Forecasts 2022-2028

Bizwit Research & Consultingが出版した調査資料(BZW22MY411)・商品コード:BZW22MY411
・発行会社(調査会社):Bizwit Research & Consulting
・発行日:2022年5月
・ページ数:約200
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥732,600見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥925,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
Bizwit Research社は、世界の注射可能式ドラッグデリバリー市場規模が2021年6,245億ドルに達し、2022年から2028年までに11.50%成長すると予想しています。本市場調査レポートでは、注射可能式ドラッグデリバリーの世界市場について調査・分析し、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、リスク分析(新型コロナウイルス感染症の影響)、種類別(自己注射器、ニードルフリー注射器、自動注射器)分析、使用法別(使い捨て式注射器、再利用可能式注射器)分析、流通チャネル別(病院薬局、小売薬局、Eコマース)分析、地域別分析、競争分析、調査プロセスなどの項目を掲載しています。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・リスク分析(新型コロナウイルス感染症の影響)
・世界の注射可能式ドラッグデリバリー市場規模:種類別(自己注射器、ニードルフリー注射器、自動注射器)
・世界の注射可能式ドラッグデリバリー市場規模:使用法別(使い捨て式注射器、再利用可能式注射器)
・世界の注射可能式ドラッグデリバリー市場規模:流通チャネル別(病院薬局、小売薬局、Eコマース)
・世界の注射可能式ドラッグデリバリー市場規模:地域別
・競争分析
・調査プロセス
【レポートの概要】

Global Injectable Drug Delivery Market is valued at approximately USD 624.5 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 11.50 % over the forecast period 2022-2028. Injectable Drug Delivery is drug delivery system that can be used instead of oral route of administration and is more effective due to its speed of action. Injectable medications are injected directly into the bloodstream using a syringe. As injectable drug delivery provides a vast surface area for absorption, it produces rapid systemic levels of absorption. Rise in demand for self-injectable devices, expanding biologics market and rising prevalence of chronic diseases have driven the adoption of Injectable Drug Delivery across the projected period.

For Instance:Chronic diseases afflicted a major share of the Chinese population in 2020. More over 500 million people were overweight or obese, and more than 400 million people suffered from excessive blood pressure. Chronic diseases accounted for 88.5 percent of all fatalities in China in 2019. Also, rising technological advancements, rise in demand for Biosimilar and generic injectable and expanding manufacturing facilities are most likely to boost the overall growth of the Injectable Drug Delivery market. However, presence of alternative routes of administration, risk of infections with needlestick injuries and product recalls can obstruct the market’s expansion over the projection period of 2021-2027.

The key regions considered for the global Injectable Drug Delivery market study include Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world. Rising prevalence of chronic diseases and growing biologics market are driving the market growth in North America. Whereas, Asia Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027. The market is expected to grow during the projected period, due to rising disposable income and growing partnerships among key players.

Major market players included in this report are:
Amgen Inc.
Antares Pharma Inc.
Becton Dickinson & Company
Consort Medical Plc
Crossjet Ltd
Medtronic Plc
Mylan N. V.
SHL Group
West Pharmaceutical Services
Ypsomed India Pvt. Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Type:
Self-Injectors
Needle-Free-Injectors
Auto-Injectors

By Usage:
Disposable Injectors
Reusable Injectors

By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
E-commerce

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Injectable Drug Delivery Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Injectable Drug Delivery Market, by Region, 2020-2028 (USD Billion)
1.2.2. Injectable Drug Delivery Market, by Type, 2020-2028 (USD Billion)
1.2.3. Injectable Drug Delivery Market, by Usage, 2020-2028 (USD Billion)
1.2.4. Injectable Drug Delivery Market, by Distribution Channel, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Injectable Drug Delivery Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Injectable Drug Delivery Market Dynamics
3.1. Injectable Drug Delivery Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Rise in demand for Self Injectable Devices
3.1.1.2. Expanding Biologics Market
3.1.1.3. Rising Prevalence of Chronic Diseases
3.1.1.4. Leading Players investing in Mergers & Acquisitions
3.1.2. Market Challenges
3.1.2.1. Presence of Alternative Routes of Administration
3.1.2.2. Risk of Infections with Needlestick Injuries
3.1.2.3. Product Recalls
3.1.3. Market Opportunities
3.1.3.1. Rising Technological Advancements
3.1.3.2. Rise in demand for Biosimilar and Generic Injectable
3.1.3.3. Expanding Manufacturing Facilities

Chapter 4. Global Injectable Drug Delivery Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the Usage
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Injectable Drug Delivery Market, by Type
6.1. Market Snapshot
6.2. Global Injectable Drug Delivery Market by Type, Performance – Potential Analysis
6.3. Global Injectable Drug Delivery Market Estimates & Forecasts by Type, 2018-2028 (USD Billion)
6.4. Injectable Drug Delivery Market, Sub Segment Analysis
6.4.1. Self-Injectors
6.4.2. Needle-Free-Injectors
6.4.3. Auto-Injectors

Chapter 7. Global Injectable Drug Delivery Market, by Usage
7.1. Market Snapshot
7.2. Global Injectable Drug Delivery Market by Usage, Performance – Potential Analysis
7.3. Global Injectable Drug Delivery Market Estimates & Forecasts by Usage, 2018-2028 (USD Billion)
7.4. Injectable Drug Delivery Market, Sub Segment Analysis
7.4.1. Disposable Injectors
7.4.2. Reusable Injectors

Chapter 8. Global Injectable Drug Delivery Market, by Distribution Channel
8.1. Market Snapshot
8.2. Global Injectable Drug Delivery Market by Distribution Channel, Performance – Potential Analysis
8.3. Global Injectable Drug Delivery Market Estimates & Forecasts by Distribution Channel, 2018-2028 (USD Billion)
8.4. Injectable Drug Delivery Market, Sub Segment Analysis
8.4.1. Hospital Pharmacies
8.4.2. Retail Pharmacies
8.4.3. E-commerce

Chapter 9. Global Injectable Drug Delivery Market, Regional Analysis

9.1. Injectable Drug Delivery Market, Regional Market Snapshot
9.2. North America Injectable Drug Delivery Market
9.2.1. U.S. Injectable Drug Delivery Market
9.2.1.1. Type breakdown estimates & forecasts, 2018-2028
9.2.1.2. Usage breakdown estimates & forecasts, 2018-2028
9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2018-2028
9.2.2. Canada Injectable Drug Delivery Market
9.3. Europe Injectable Drug Delivery Market Snapshot
9.3.1. U.K. Injectable Drug Delivery Market
9.3.2. Germany Injectable Drug Delivery Market
9.3.3. France Injectable Drug Delivery Market
9.3.4. Spain Injectable Drug Delivery Market
9.3.5. Italy Injectable Drug Delivery Market
9.3.6. Rest of Europe Injectable Drug Delivery Market
9.4. Asia-Pacific Injectable Drug Delivery Market Snapshot
9.4.1. China Injectable Drug Delivery Market
9.4.2. India Injectable Drug Delivery Market
9.4.3. Japan Injectable Drug Delivery Market
9.4.4. Australia Injectable Drug Delivery Market
9.4.5. South Korea Injectable Drug Delivery Market
9.4.6. Rest of Asia Pacific Injectable Drug Delivery Market
9.5. Latin America Injectable Drug Delivery Market Snapshot
9.5.1. Brazil Injectable Drug Delivery Market
9.5.2. Mexico Injectable Drug Delivery Market
9.6. Rest of The World Injectable Drug Delivery Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1 Amgen Inc.
10.2.1.1 Key Information
10.2.1.2 Overview
10.2.1.3 Financial (Subject to Data Availability)
10.2.1.4 Usage Summary
10.2.1.5 Recent Developments

10.2.2 Antares Pharma Inc.
10.2.3 Becton Dickinson & Company
10.2.4 Consort Medical Plc
10.2.5 Crossjet Ltd
10.2.6 Medtronic Plc
10.2.7 Mylan N. V.
10.2.8 SHL Group
10.2.9 West Pharmaceutical Services
10.2.10 Ypsomed India Pvt. Ltd.
Chapter 11. Research Process

11.1 Research Process
11.1.1 Data Mining
11.1.2 Analysis
11.1.3 Market Estimation
11.1.4 Validation
11.1.5 Publishing
11.2 Research Attributes
11.3 Research Assumption



★調査レポート[注射可能式ドラッグデリバリーの世界市場2022-2028:種類別、使用法別、流通チャネル別、地域別] (コード:BZW22MY411)販売に関する免責事項を必ずご確認ください。
★調査レポート[注射可能式ドラッグデリバリーの世界市場2022-2028:種類別、使用法別、流通チャネル別、地域別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆